Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2023
FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimeticSteven R Lentz, Pratima Chowdary, Lidia Gil, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 18, 2021
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional studyCarmen Escuriola Ettingshausen, Olga Katsarou, Barbara Faganel Kotnik, et al.Thrombosis and Haemostasis|December 31, 2019
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia AAndreas Tiede, Ana Rosa Cid, Georg Goldmann, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 8, 2018
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trialSteven R Lentz, Dragana Janic, Kaan Kavakli, et al.Therapeutics and Clinical Risk Management|July 2, 2020
Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 TrialRunhui Wu, Jing Sun, Weiqun Xu, et al.Pageof 2